Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9739277
[patent_doc_number] => 20140274996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'TAZOBACTAM AND CEFTOLOZANE ANTIBIOTIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/214367
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11425
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214367
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214367 | TAZOBACTAM AND CEFTOLOZANE ANTIBIOTIC COMPOSITIONS | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10499586
[patent_doc_number] => 09227978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Covalent inhibitors of Kras G12C'
[patent_app_type] => utility
[patent_app_number] => 14/212656
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 66412
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/212656 | Covalent inhibitors of Kras G12C | Mar 13, 2014 | Issued |
Array
(
[id] => 9793357
[patent_doc_number] => 20150005300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/210277
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40336
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210277
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210277 | Pyridazinone compounds and methods for the treatment of cystic fibrosis | Mar 12, 2014 | Issued |
Array
(
[id] => 10968192
[patent_doc_number] => 20140371225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/210273
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21223
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210273
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210273 | Pyridazinone compounds and methods for the treatment of cystic fibrosis | Mar 12, 2014 | Issued |
Array
(
[id] => 9616848
[patent_doc_number] => 20140206705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'CRYSTALS OF SALTS OF PHENYLALANINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/206540
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15051
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206540
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/206540 | Crystals of salts of phenylalanine derivatives | Mar 11, 2014 | Issued |
Array
(
[id] => 10279761
[patent_doc_number] => 20150164758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'TYROSINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/412185
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9877
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412185 | Tyrosinase inhibitors | Mar 5, 2014 | Issued |
Array
(
[id] => 11176821
[patent_doc_number] => 09408796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Cosmetic compositions for improving the appearance of skin'
[patent_app_type] => utility
[patent_app_number] => 14/409506
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409506 | Cosmetic compositions for improving the appearance of skin | Mar 5, 2014 | Issued |
Array
(
[id] => 10662658
[patent_doc_number] => 20160008803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'WATER-INSOLUBLE RUTHENIUM CATALYST COMPOSITION FOR USE IN AQUEOUS HYDROGENATION REACTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/772393
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7183
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772393
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772393 | Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions | Mar 4, 2014 | Issued |
Array
(
[id] => 9562227
[patent_doc_number] => 20140179919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'COMPOUNDS, COMPOSITIONS, METHODS OF SYNTHESIS, AND METHODS OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/191201
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 170401
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191201
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/191201 | COMPOUNDS, COMPOSITIONS, METHODS OF SYNTHESIS, AND METHODS OF TREATMENT | Feb 25, 2014 | Abandoned |
Array
(
[id] => 10192926
[patent_doc_number] => 09221823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Crystal form of pyrrolidylthiocarbapenem derivative'
[patent_app_type] => utility
[patent_app_number] => 14/187010
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4949
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187010
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/187010 | Crystal form of pyrrolidylthiocarbapenem derivative | Feb 20, 2014 | Issued |
Array
(
[id] => 11357335
[patent_doc_number] => 09533976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'γ-diketones as WNT/β-catenin signaling pathway activators'
[patent_app_type] => utility
[patent_app_number] => 14/187063
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69669
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187063
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/187063 | γ-diketones as WNT/β-catenin signaling pathway activators | Feb 20, 2014 | Issued |
Array
(
[id] => 10954614
[patent_doc_number] => 20140357636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'Treatment of Skeletal-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/186902
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13937
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186902
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/186902 | Treatment of Skeletal-Related Disorders | Feb 20, 2014 | Abandoned |
Array
(
[id] => 9839799
[patent_doc_number] => 20150031881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/186486
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 23069
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186486
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/186486 | PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF | Feb 20, 2014 | Abandoned |
Array
(
[id] => 9635442
[patent_doc_number] => 20140213551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'COMPOUNDS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/182793
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8121
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14182793
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/182793 | Compounds and compositions | Feb 17, 2014 | Issued |
Array
(
[id] => 10663528
[patent_doc_number] => 20160009673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'UNSATURATED FATTY ACID ESTER-BASED COMPOSITIONS USEFUL AS PLASTIC ADDITIVES'
[patent_app_type] => utility
[patent_app_number] => 14/769489
[patent_app_country] => US
[patent_app_date] => 2014-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8051
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14769489
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/769489 | Unsaturated fatty acid ester-based compositions useful as plastic additives | Feb 16, 2014 | Issued |
Array
(
[id] => 10468520
[patent_doc_number] => 20150353536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Complex targeting hepatitis B virus'
[patent_app_type] => utility
[patent_app_number] => 14/351575
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4386
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351575 | Complex targeting hepatitis B virus | Feb 12, 2014 | Issued |
Array
(
[id] => 10720431
[patent_doc_number] => 20160066579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'PHOSPHORUS FUNCTIONAL ANTIMICROBIAL COATINGS FOR METAL SURFACES'
[patent_app_type] => utility
[patent_app_number] => 14/767052
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 16769
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767052
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767052 | Phosphorus functional antimicrobial coatings for metal surfaces | Feb 11, 2014 | Issued |
Array
(
[id] => 11283674
[patent_doc_number] => 09499517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Substituted prolines / piperidines as orexin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/179432
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 89193
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179432
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179432 | Substituted prolines / piperidines as orexin receptor antagonists | Feb 11, 2014 | Issued |
Array
(
[id] => 10018557
[patent_doc_number] => 09061026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Oligomer-diarylpiperazine conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/175410
[patent_app_country] => US
[patent_app_date] => 2014-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24286
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14175410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/175410 | Oligomer-diarylpiperazine conjugates | Feb 6, 2014 | Issued |
Array
(
[id] => 9996099
[patent_doc_number] => 09040697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Process for the production of moxonidine'
[patent_app_type] => utility
[patent_app_number] => 14/173688
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3040
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/173688 | Process for the production of moxonidine | Feb 4, 2014 | Issued |